These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients. Ritenour CW; Abbott JT; Goodman M; Alazraki N; Marshall FF; Issa MM ScientificWorldJournal; 2009 Oct; 9():1040-5. PubMed ID: 19802499 [TBL] [Abstract][Full Text] [Related]
26. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610 [TBL] [Abstract][Full Text] [Related]
27. Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. Okotie OT; Aronson WJ; Wieder JA; Liao Y; Dorey F; DeKERNION JB; Freedland SJ J Urol; 2004 Jun; 171(6 Pt 1):2260-4. PubMed ID: 15126798 [TBL] [Abstract][Full Text] [Related]
28. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis. Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494 [TBL] [Abstract][Full Text] [Related]
29. Using prostate-specific antigen to eliminate the staging radionuclide bone scan. Lee CT; Oesterling JE Urol Clin North Am; 1997 May; 24(2):389-94. PubMed ID: 9126236 [TBL] [Abstract][Full Text] [Related]
30. [Utility of SPECT/CT scan for anatomical localization of pararectal and presacral sentinel nodes in prostate cancer]. Chícharo de Freitas JR; KleinJan GH; van der Poel HG; van den Berg NS; Vegt E; Stokkel MP; Valdés Olmos RA Rev Esp Med Nucl Imagen Mol; 2015; 34(1):19-23. PubMed ID: 25448419 [TBL] [Abstract][Full Text] [Related]
31. Indications for laparoscopic pelvic lymph node dissection in the staging of prostate cancer. Patel MI; Katelaris PM Aust N Z J Surg; 1995 Apr; 65(4):233-6. PubMed ID: 7536410 [TBL] [Abstract][Full Text] [Related]
32. [Staging pelvic lymphadenectomy for carcinoma of the prostate]. Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215 [TBL] [Abstract][Full Text] [Related]
33. Clinical staging of prostatic cancer: new modalities. Spirnak JP; Resnick MI Urol Clin North Am; 1984 May; 11(2):221-35. PubMed ID: 6203203 [TBL] [Abstract][Full Text] [Related]
34. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse]. Osmonov DK; Aksenov AV; Jünemann KP Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670 [TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950 [TBL] [Abstract][Full Text] [Related]
36. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement. Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681 [TBL] [Abstract][Full Text] [Related]
37. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Flanigan RC; McKay TC; Olson M; Shankey TV; Pyle J; Waters WB Urology; 1996 Sep; 48(3):428-32. PubMed ID: 8804497 [TBL] [Abstract][Full Text] [Related]
38. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study. Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275 [TBL] [Abstract][Full Text] [Related]
39. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort. KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247 [TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I Urology; 2001 Feb; 57(2):225-9. PubMed ID: 11182325 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]